nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ALB—hematologic cancer	0.0598	1	CbGaD
Sevoflurane—CYP2A6—Methoxsalen—hematologic cancer	0.0407	0.0848	CbGbCtD
Sevoflurane—CYP2B6—Thiotepa—hematologic cancer	0.0341	0.071	CbGbCtD
Sevoflurane—CYP2A6—Ifosfamide—hematologic cancer	0.0297	0.0619	CbGbCtD
Sevoflurane—CYP2E1—Thalidomide—hematologic cancer	0.0223	0.0464	CbGbCtD
Sevoflurane—CYP2A6—Prednisolone—hematologic cancer	0.0198	0.0412	CbGbCtD
Sevoflurane—CYP2B6—Ifosfamide—hematologic cancer	0.0193	0.0403	CbGbCtD
Sevoflurane—CYP2E1—Dacarbazine—hematologic cancer	0.0192	0.0399	CbGbCtD
Sevoflurane—ALB—Imatinib—hematologic cancer	0.0181	0.0377	CbGbCtD
Sevoflurane—CYP2B6—Nilotinib—hematologic cancer	0.0168	0.035	CbGbCtD
Sevoflurane—CYP2E1—Mitoxantrone—hematologic cancer	0.0149	0.0309	CbGbCtD
Sevoflurane—CYP3A4—Bexarotene—hematologic cancer	0.0126	0.0263	CbGbCtD
Sevoflurane—ALB—Prednisone—hematologic cancer	0.0119	0.0248	CbGbCtD
Sevoflurane—CYP3A4—Lomustine—hematologic cancer	0.0118	0.0245	CbGbCtD
Sevoflurane—CYP3A4—Busulfan—hematologic cancer	0.0118	0.0245	CbGbCtD
Sevoflurane—CYP2A6—Dexamethasone—hematologic cancer	0.0117	0.0243	CbGbCtD
Sevoflurane—CYP2B6—Irinotecan—hematologic cancer	0.0115	0.024	CbGbCtD
Sevoflurane—ALB—Irinotecan—hematologic cancer	0.0113	0.0236	CbGbCtD
Sevoflurane—CYP3A4—Thiotepa—hematologic cancer	0.0105	0.0218	CbGbCtD
Sevoflurane—CYP2B6—Cisplatin—hematologic cancer	0.00941	0.0196	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—hematologic cancer	0.00937	0.0195	CbGbCtD
Sevoflurane—CYP3A4—Methoxsalen—hematologic cancer	0.00814	0.017	CbGbCtD
Sevoflurane—CYP3A4—Bortezomib—hematologic cancer	0.00775	0.0161	CbGbCtD
Sevoflurane—CYP2E1—Dexamethasone—hematologic cancer	0.0077	0.016	CbGbCtD
Sevoflurane—CYP2B6—Dexamethasone—hematologic cancer	0.0076	0.0158	CbGbCtD
Sevoflurane—CYP3A4—Daunorubicin—hematologic cancer	0.00741	0.0154	CbGbCtD
Sevoflurane—CYP3A4—Cytarabine—hematologic cancer	0.00654	0.0136	CbGbCtD
Sevoflurane—CYP3A4—Teniposide—hematologic cancer	0.00644	0.0134	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—hematologic cancer	0.0063	0.0131	CbGbCtD
Sevoflurane—ALB—Methotrexate—hematologic cancer	0.00599	0.0125	CbGbCtD
Sevoflurane—CYP3A4—Ifosfamide—hematologic cancer	0.00594	0.0124	CbGbCtD
Sevoflurane—CYP3A4—Imatinib—hematologic cancer	0.00568	0.0118	CbGbCtD
Sevoflurane—CYP3A4—Ruxolitinib—hematologic cancer	0.00534	0.0111	CbGbCtD
Sevoflurane—CYP3A4—Nilotinib—hematologic cancer	0.00516	0.0107	CbGbCtD
Sevoflurane—CYP3A4—Vinorelbine—hematologic cancer	0.00511	0.0107	CbGbCtD
Sevoflurane—CYP3A4—Triamcinolone—hematologic cancer	0.00468	0.00974	CbGbCtD
Sevoflurane—CYP3A4—Dasatinib—hematologic cancer	0.00456	0.00949	CbGbCtD
Sevoflurane—CYP3A4—Mitoxantrone—hematologic cancer	0.0045	0.00938	CbGbCtD
Sevoflurane—CYP3A4—Betamethasone—hematologic cancer	0.00401	0.00836	CbGbCtD
Sevoflurane—CYP3A4—Prednisolone—hematologic cancer	0.00396	0.00825	CbGbCtD
Sevoflurane—CYP3A4—Prednisone—hematologic cancer	0.00374	0.00779	CbGbCtD
Sevoflurane—CYP3A4—Irinotecan—hematologic cancer	0.00355	0.00738	CbGbCtD
Sevoflurane—CYP3A4—Vinblastine—hematologic cancer	0.00315	0.00656	CbGbCtD
Sevoflurane—CYP3A4—Vincristine—hematologic cancer	0.0031	0.00645	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—hematologic cancer	0.00284	0.00591	CbGbCtD
Sevoflurane—CYP3A4—Dexamethasone—hematologic cancer	0.00233	0.00486	CbGbCtD
Sevoflurane—ND1—hematopoietic system—hematologic cancer	0.002	0.0455	CbGeAlD
Sevoflurane—CYP3A4—Doxorubicin—hematologic cancer	0.00194	0.00403	CbGbCtD
Sevoflurane—KCNK2—testis—hematologic cancer	0.00164	0.0372	CbGeAlD
Sevoflurane—ATP2C1—hematopoietic system—hematologic cancer	0.00159	0.0362	CbGeAlD
Sevoflurane—ND1—gonad—hematologic cancer	0.00152	0.0346	CbGeAlD
Sevoflurane—GRIA1—lung—hematologic cancer	0.00135	0.0307	CbGeAlD
Sevoflurane—ND1—bone marrow—hematologic cancer	0.00128	0.0292	CbGeAlD
Sevoflurane—GRIA1—testis—hematologic cancer	0.00128	0.029	CbGeAlD
Sevoflurane—GABRG3—testis—hematologic cancer	0.00124	0.0281	CbGeAlD
Sevoflurane—ATP5D—gonad—hematologic cancer	0.00123	0.0279	CbGeAlD
Sevoflurane—ATP2C1—gonad—hematologic cancer	0.00121	0.0275	CbGeAlD
Sevoflurane—KCNK2—lymph node—hematologic cancer	0.00119	0.027	CbGeAlD
Sevoflurane—ND1—lung—hematologic cancer	0.00116	0.0264	CbGeAlD
Sevoflurane—ND1—testis—hematologic cancer	0.0011	0.0249	CbGeAlD
Sevoflurane—ATP5D—blood—hematologic cancer	0.00107	0.0243	CbGeAlD
Sevoflurane—ATP2C1—blood—hematologic cancer	0.00106	0.024	CbGeAlD
Sevoflurane—ATP5D—bone marrow—hematologic cancer	0.00103	0.0235	CbGeAlD
Sevoflurane—GABRD—testis—hematologic cancer	0.00102	0.0232	CbGeAlD
Sevoflurane—ATP2C1—bone marrow—hematologic cancer	0.00102	0.0232	CbGeAlD
Sevoflurane—GABRA5—testis—hematologic cancer	0.00095	0.0216	CbGeAlD
Sevoflurane—ATP5D—lung—hematologic cancer	0.000937	0.0213	CbGeAlD
Sevoflurane—ATP2C1—lung—hematologic cancer	0.000925	0.021	CbGeAlD
Sevoflurane—GABRP—lung—hematologic cancer	0.000907	0.0206	CbGeAlD
Sevoflurane—GABRA3—testis—hematologic cancer	0.000885	0.0201	CbGeAlD
Sevoflurane—ATP5D—testis—hematologic cancer	0.000885	0.0201	CbGeAlD
Sevoflurane—ATP2C1—testis—hematologic cancer	0.000873	0.0198	CbGeAlD
Sevoflurane—ND1—lymph node—hematologic cancer	0.000795	0.0181	CbGeAlD
Sevoflurane—CYP2A6—lung—hematologic cancer	0.00079	0.0179	CbGeAlD
Sevoflurane—GABRB3—gonad—hematologic cancer	0.000768	0.0175	CbGeAlD
Sevoflurane—GABRB2—lung—hematologic cancer	0.000764	0.0174	CbGeAlD
Sevoflurane—GABRB2—testis—hematologic cancer	0.000721	0.0164	CbGeAlD
Sevoflurane—GABRE—lung—hematologic cancer	0.000692	0.0157	CbGeAlD
Sevoflurane—CYP2B6—hematopoietic system—hematologic cancer	0.000685	0.0156	CbGeAlD
Sevoflurane—GABRE—testis—hematologic cancer	0.000653	0.0148	CbGeAlD
Sevoflurane—CYP2E1—hematopoietic system—hematologic cancer	0.000643	0.0146	CbGeAlD
Sevoflurane—ATP5D—lymph node—hematologic cancer	0.000641	0.0146	CbGeAlD
Sevoflurane—ATP2C1—lymph node—hematologic cancer	0.000633	0.0144	CbGeAlD
Sevoflurane—ALB—testis—hematologic cancer	0.000596	0.0135	CbGeAlD
Sevoflurane—GABRB3—lung—hematologic cancer	0.000587	0.0133	CbGeAlD
Sevoflurane—GABRB3—testis—hematologic cancer	0.000554	0.0126	CbGeAlD
Sevoflurane—CYP2B6—gonad—hematologic cancer	0.000521	0.0118	CbGeAlD
Sevoflurane—CYP3A4—hematopoietic system—hematologic cancer	0.000517	0.0118	CbGeAlD
Sevoflurane—GABRA2—lymph node—hematologic cancer	0.000478	0.0108	CbGeAlD
Sevoflurane—GABRE—lymph node—hematologic cancer	0.000474	0.0108	CbGeAlD
Sevoflurane—CYP2B6—blood—hematologic cancer	0.000454	0.0103	CbGeAlD
Sevoflurane—ALB—lymph node—hematologic cancer	0.000432	0.00981	CbGeAlD
Sevoflurane—CYP2E1—blood—hematologic cancer	0.000426	0.00968	CbGeAlD
Sevoflurane—CYP2B6—lung—hematologic cancer	0.000398	0.00904	CbGeAlD
Sevoflurane—CYP2B6—testis—hematologic cancer	0.000375	0.00853	CbGeAlD
Sevoflurane—CYP2E1—lung—hematologic cancer	0.000373	0.00848	CbGeAlD
Sevoflurane—CYP2E1—testis—hematologic cancer	0.000352	0.008	CbGeAlD
Sevoflurane—CYP3A4—blood—hematologic cancer	0.000343	0.00778	CbGeAlD
Sevoflurane—Hepatitis—Epirubicin—hematologic cancer	5.23e-05	0.00017	CcSEcCtD
Sevoflurane—Syncope—Prednisone—hematologic cancer	5.23e-05	0.00017	CcSEcCtD
Sevoflurane—Vomiting—Vincristine—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Sevoflurane—Urticaria—Prednisolone—hematologic cancer	5.2e-05	0.000169	CcSEcCtD
Sevoflurane—Asthenia—Cisplatin—hematologic cancer	5.2e-05	0.000169	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—hematologic cancer	5.2e-05	0.000169	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—hematologic cancer	5.19e-05	0.000169	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—hematologic cancer	5.17e-05	0.000168	CcSEcCtD
Sevoflurane—Rash—Vincristine—hematologic cancer	5.16e-05	0.000168	CcSEcCtD
Sevoflurane—Dermatitis—Vincristine—hematologic cancer	5.16e-05	0.000168	CcSEcCtD
Sevoflurane—Pain—Triamcinolone—hematologic cancer	5.15e-05	0.000167	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—hematologic cancer	5.13e-05	0.000167	CcSEcCtD
Sevoflurane—Headache—Vincristine—hematologic cancer	5.13e-05	0.000167	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisone—hematologic cancer	5.12e-05	0.000166	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.1e-05	0.000166	CcSEcCtD
Sevoflurane—Hypotension—Dexamethasone—hematologic cancer	5.1e-05	0.000166	CcSEcCtD
Sevoflurane—Hypotension—Betamethasone—hematologic cancer	5.1e-05	0.000166	CcSEcCtD
Sevoflurane—Nausea—Carmustine—hematologic cancer	5.1e-05	0.000165	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—hematologic cancer	5.08e-05	0.000165	CcSEcCtD
Sevoflurane—Vomiting—Mitoxantrone—hematologic cancer	5.07e-05	0.000165	CcSEcCtD
Sevoflurane—Vomiting—Irinotecan—hematologic cancer	5.07e-05	0.000165	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—hematologic cancer	5.05e-05	0.000164	CcSEcCtD
Sevoflurane—Nausea—Alitretinoin—hematologic cancer	5.05e-05	0.000164	CcSEcCtD
Sevoflurane—Convulsion—Prednisone—hematologic cancer	5.05e-05	0.000164	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—hematologic cancer	5.04e-05	0.000164	CcSEcCtD
Sevoflurane—Hypertension—Prednisone—hematologic cancer	5.03e-05	0.000163	CcSEcCtD
Sevoflurane—Rash—Mitoxantrone—hematologic cancer	5.03e-05	0.000163	CcSEcCtD
Sevoflurane—Rash—Irinotecan—hematologic cancer	5.03e-05	0.000163	CcSEcCtD
Sevoflurane—Dermatitis—Mitoxantrone—hematologic cancer	5.02e-05	0.000163	CcSEcCtD
Sevoflurane—Dermatitis—Irinotecan—hematologic cancer	5.02e-05	0.000163	CcSEcCtD
Sevoflurane—Chills—Methotrexate—hematologic cancer	5.02e-05	0.000163	CcSEcCtD
Sevoflurane—Headache—Mitoxantrone—hematologic cancer	5e-05	0.000162	CcSEcCtD
Sevoflurane—Headache—Irinotecan—hematologic cancer	5e-05	0.000162	CcSEcCtD
Sevoflurane—Nausea—Ifosfamide—hematologic cancer	4.99e-05	0.000162	CcSEcCtD
Sevoflurane—Feeling abnormal—Triamcinolone—hematologic cancer	4.96e-05	0.000161	CcSEcCtD
Sevoflurane—Vomiting—Gemcitabine—hematologic cancer	4.94e-05	0.00016	CcSEcCtD
Sevoflurane—Insomnia—Dexamethasone—hematologic cancer	4.94e-05	0.00016	CcSEcCtD
Sevoflurane—Insomnia—Betamethasone—hematologic cancer	4.94e-05	0.00016	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—hematologic cancer	4.93e-05	0.00016	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.93e-05	0.00016	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—hematologic cancer	4.9e-05	0.000159	CcSEcCtD
Sevoflurane—Rash—Gemcitabine—hematologic cancer	4.9e-05	0.000159	CcSEcCtD
Sevoflurane—Dermatitis—Gemcitabine—hematologic cancer	4.89e-05	0.000159	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—hematologic cancer	4.89e-05	0.000159	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—hematologic cancer	4.87e-05	0.000158	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—hematologic cancer	4.87e-05	0.000158	CcSEcCtD
Sevoflurane—Headache—Gemcitabine—hematologic cancer	4.87e-05	0.000158	CcSEcCtD
Sevoflurane—Nausea—Vincristine—hematologic cancer	4.86e-05	0.000158	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—hematologic cancer	4.86e-05	0.000158	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—hematologic cancer	4.84e-05	0.000157	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—hematologic cancer	4.84e-05	0.000157	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisolone—hematologic cancer	4.82e-05	0.000157	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—hematologic cancer	4.81e-05	0.000156	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—hematologic cancer	4.78e-05	0.000155	CcSEcCtD
Sevoflurane—Urticaria—Triamcinolone—hematologic cancer	4.78e-05	0.000155	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—hematologic cancer	4.77e-05	0.000155	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—hematologic cancer	4.76e-05	0.000155	CcSEcCtD
Sevoflurane—Body temperature increased—Triamcinolone—hematologic cancer	4.76e-05	0.000154	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisone—hematologic cancer	4.76e-05	0.000154	CcSEcCtD
Sevoflurane—Oedema—Prednisone—hematologic cancer	4.76e-05	0.000154	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—hematologic cancer	4.75e-05	0.000154	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—hematologic cancer	4.75e-05	0.000154	CcSEcCtD
Sevoflurane—Nausea—Mitoxantrone—hematologic cancer	4.74e-05	0.000154	CcSEcCtD
Sevoflurane—Nausea—Irinotecan—hematologic cancer	4.74e-05	0.000154	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—hematologic cancer	4.73e-05	0.000154	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—hematologic cancer	4.72e-05	0.000153	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.71e-05	0.000153	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.71e-05	0.000153	CcSEcCtD
Sevoflurane—Chills—Epirubicin—hematologic cancer	4.7e-05	0.000153	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—hematologic cancer	4.69e-05	0.000152	CcSEcCtD
Sevoflurane—Shock—Prednisone—hematologic cancer	4.68e-05	0.000152	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—hematologic cancer	4.68e-05	0.000152	CcSEcCtD
Sevoflurane—Pain—Dexamethasone—hematologic cancer	4.67e-05	0.000152	CcSEcCtD
Sevoflurane—Pain—Betamethasone—hematologic cancer	4.67e-05	0.000152	CcSEcCtD
Sevoflurane—Nervous system disorder—Prednisone—hematologic cancer	4.66e-05	0.000151	CcSEcCtD
Sevoflurane—Tachycardia—Prednisone—hematologic cancer	4.64e-05	0.000151	CcSEcCtD
Sevoflurane—Skin disorder—Prednisone—hematologic cancer	4.62e-05	0.00015	CcSEcCtD
Sevoflurane—Nausea—Gemcitabine—hematologic cancer	4.62e-05	0.00015	CcSEcCtD
Sevoflurane—Vomiting—Cisplatin—hematologic cancer	4.6e-05	0.00015	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—hematologic cancer	4.59e-05	0.000149	CcSEcCtD
Sevoflurane—Rash—Cisplatin—hematologic cancer	4.57e-05	0.000148	CcSEcCtD
Sevoflurane—Dermatitis—Cisplatin—hematologic cancer	4.56e-05	0.000148	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—hematologic cancer	4.56e-05	0.000148	CcSEcCtD
Sevoflurane—Feeling abnormal—Betamethasone—hematologic cancer	4.5e-05	0.000146	CcSEcCtD
Sevoflurane—Feeling abnormal—Dexamethasone—hematologic cancer	4.5e-05	0.000146	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—hematologic cancer	4.5e-05	0.000146	CcSEcCtD
Sevoflurane—Tension—Epirubicin—hematologic cancer	4.47e-05	0.000145	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—hematologic cancer	4.46e-05	0.000145	CcSEcCtD
Sevoflurane—Hypersensitivity—Triamcinolone—hematologic cancer	4.43e-05	0.000144	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—hematologic cancer	4.43e-05	0.000144	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—hematologic cancer	4.39e-05	0.000143	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—hematologic cancer	4.39e-05	0.000142	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—hematologic cancer	4.37e-05	0.000142	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—hematologic cancer	4.37e-05	0.000142	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—hematologic cancer	4.35e-05	0.000141	CcSEcCtD
Sevoflurane—Urticaria—Dexamethasone—hematologic cancer	4.34e-05	0.000141	CcSEcCtD
Sevoflurane—Urticaria—Betamethasone—hematologic cancer	4.34e-05	0.000141	CcSEcCtD
Sevoflurane—Dizziness—Prednisolone—hematologic cancer	4.33e-05	0.000141	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—hematologic cancer	4.33e-05	0.000141	CcSEcCtD
Sevoflurane—Asthenia—Triamcinolone—hematologic cancer	4.32e-05	0.00014	CcSEcCtD
Sevoflurane—Body temperature increased—Dexamethasone—hematologic cancer	4.32e-05	0.00014	CcSEcCtD
Sevoflurane—Body temperature increased—Betamethasone—hematologic cancer	4.32e-05	0.00014	CcSEcCtD
Sevoflurane—Nausea—Cisplatin—hematologic cancer	4.3e-05	0.00014	CcSEcCtD
Sevoflurane—Insomnia—Prednisone—hematologic cancer	4.3e-05	0.00014	CcSEcCtD
Sevoflurane—Pruritus—Triamcinolone—hematologic cancer	4.26e-05	0.000138	CcSEcCtD
Sevoflurane—Cough—Methotrexate—hematologic cancer	4.25e-05	0.000138	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—hematologic cancer	4.24e-05	0.000138	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—hematologic cancer	4.22e-05	0.000137	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—hematologic cancer	4.22e-05	0.000137	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—hematologic cancer	4.22e-05	0.000137	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—hematologic cancer	4.19e-05	0.000136	CcSEcCtD
Sevoflurane—Rash—Etoposide—hematologic cancer	4.18e-05	0.000136	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—hematologic cancer	4.18e-05	0.000136	CcSEcCtD
Sevoflurane—Headache—Etoposide—hematologic cancer	4.16e-05	0.000135	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—hematologic cancer	4.15e-05	0.000135	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—hematologic cancer	4.14e-05	0.000134	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—hematologic cancer	4.13e-05	0.000134	CcSEcCtD
Sevoflurane—Rash—Prednisolone—hematologic cancer	4.13e-05	0.000134	CcSEcCtD
Sevoflurane—Dermatitis—Prednisolone—hematologic cancer	4.12e-05	0.000134	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.12e-05	0.000134	CcSEcCtD
Sevoflurane—Headache—Prednisolone—hematologic cancer	4.1e-05	0.000133	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—hematologic cancer	4.1e-05	0.000133	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—hematologic cancer	4.09e-05	0.000133	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—hematologic cancer	4.01e-05	0.00013	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—hematologic cancer	4.01e-05	0.00013	CcSEcCtD
Sevoflurane—Dizziness—Triamcinolone—hematologic cancer	3.98e-05	0.000129	CcSEcCtD
Sevoflurane—Cough—Epirubicin—hematologic cancer	3.98e-05	0.000129	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—hematologic cancer	3.97e-05	0.000129	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—hematologic cancer	3.95e-05	0.000128	CcSEcCtD
Sevoflurane—Nausea—Etoposide—hematologic cancer	3.94e-05	0.000128	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—hematologic cancer	3.93e-05	0.000128	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisone—hematologic cancer	3.92e-05	0.000127	CcSEcCtD
Sevoflurane—Asthenia—Betamethasone—hematologic cancer	3.92e-05	0.000127	CcSEcCtD
Sevoflurane—Asthenia—Dexamethasone—hematologic cancer	3.92e-05	0.000127	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—hematologic cancer	3.9e-05	0.000127	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—hematologic cancer	3.89e-05	0.000126	CcSEcCtD
Sevoflurane—Nausea—Prednisolone—hematologic cancer	3.89e-05	0.000126	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—hematologic cancer	3.88e-05	0.000126	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—hematologic cancer	3.87e-05	0.000126	CcSEcCtD
Sevoflurane—Pruritus—Betamethasone—hematologic cancer	3.86e-05	0.000125	CcSEcCtD
Sevoflurane—Pruritus—Dexamethasone—hematologic cancer	3.86e-05	0.000125	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—hematologic cancer	3.86e-05	0.000125	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.85e-05	0.000125	CcSEcCtD
Sevoflurane—Vomiting—Triamcinolone—hematologic cancer	3.83e-05	0.000124	CcSEcCtD
Sevoflurane—Rash—Triamcinolone—hematologic cancer	3.79e-05	0.000123	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—hematologic cancer	3.79e-05	0.000123	CcSEcCtD
Sevoflurane—Dermatitis—Triamcinolone—hematologic cancer	3.79e-05	0.000123	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—hematologic cancer	3.78e-05	0.000123	CcSEcCtD
Sevoflurane—Urticaria—Prednisone—hematologic cancer	3.78e-05	0.000123	CcSEcCtD
Sevoflurane—Headache—Triamcinolone—hematologic cancer	3.77e-05	0.000122	CcSEcCtD
Sevoflurane—Body temperature increased—Prednisone—hematologic cancer	3.76e-05	0.000122	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—hematologic cancer	3.75e-05	0.000122	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—hematologic cancer	3.72e-05	0.000121	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—hematologic cancer	3.72e-05	0.000121	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—hematologic cancer	3.71e-05	0.000121	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—hematologic cancer	3.71e-05	0.00012	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—hematologic cancer	3.68e-05	0.000119	CcSEcCtD
Sevoflurane—Shock—Epirubicin—hematologic cancer	3.66e-05	0.000119	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—hematologic cancer	3.65e-05	0.000119	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—hematologic cancer	3.65e-05	0.000118	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—hematologic cancer	3.64e-05	0.000118	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—hematologic cancer	3.64e-05	0.000118	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—hematologic cancer	3.63e-05	0.000118	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—hematologic cancer	3.61e-05	0.000117	CcSEcCtD
Sevoflurane—Dizziness—Betamethasone—hematologic cancer	3.61e-05	0.000117	CcSEcCtD
Sevoflurane—Dizziness—Dexamethasone—hematologic cancer	3.61e-05	0.000117	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—hematologic cancer	3.59e-05	0.000117	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—hematologic cancer	3.59e-05	0.000117	CcSEcCtD
Sevoflurane—Nausea—Triamcinolone—hematologic cancer	3.57e-05	0.000116	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.56e-05	0.000116	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—hematologic cancer	3.54e-05	0.000115	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—hematologic cancer	3.53e-05	0.000115	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—hematologic cancer	3.51e-05	0.000114	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisone—hematologic cancer	3.5e-05	0.000114	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—hematologic cancer	3.48e-05	0.000113	CcSEcCtD
Sevoflurane—Vomiting—Dexamethasone—hematologic cancer	3.47e-05	0.000113	CcSEcCtD
Sevoflurane—Vomiting—Betamethasone—hematologic cancer	3.47e-05	0.000113	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—hematologic cancer	3.47e-05	0.000113	CcSEcCtD
Sevoflurane—Rash—Betamethasone—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Rash—Dexamethasone—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Dermatitis—Dexamethasone—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Dermatitis—Betamethasone—hematologic cancer	3.44e-05	0.000112	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.43e-05	0.000111	CcSEcCtD
Sevoflurane—Headache—Dexamethasone—hematologic cancer	3.42e-05	0.000111	CcSEcCtD
Sevoflurane—Headache—Betamethasone—hematologic cancer	3.42e-05	0.000111	CcSEcCtD
Sevoflurane—Asthenia—Prednisone—hematologic cancer	3.41e-05	0.000111	CcSEcCtD
Sevoflurane—Pain—Methotrexate—hematologic cancer	3.4e-05	0.00011	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—hematologic cancer	3.39e-05	0.00011	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—hematologic cancer	3.37e-05	0.00011	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—hematologic cancer	3.37e-05	0.000109	CcSEcCtD
Sevoflurane—Pruritus—Prednisone—hematologic cancer	3.36e-05	0.000109	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—hematologic cancer	3.36e-05	0.000109	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—hematologic cancer	3.36e-05	0.000109	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000109	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—hematologic cancer	3.32e-05	0.000108	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—hematologic cancer	3.31e-05	0.000107	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—hematologic cancer	3.27e-05	0.000106	CcSEcCtD
Sevoflurane—Nausea—Dexamethasone—hematologic cancer	3.24e-05	0.000105	CcSEcCtD
Sevoflurane—Nausea—Betamethasone—hematologic cancer	3.24e-05	0.000105	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—hematologic cancer	3.22e-05	0.000104	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.21e-05	0.000104	CcSEcCtD
Sevoflurane—Pain—Epirubicin—hematologic cancer	3.18e-05	0.000103	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—hematologic cancer	3.16e-05	0.000103	CcSEcCtD
Sevoflurane—Dizziness—Prednisone—hematologic cancer	3.14e-05	0.000102	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—hematologic cancer	3.14e-05	0.000102	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—hematologic cancer	3.11e-05	0.000101	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—hematologic cancer	3.07e-05	9.96e-05	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—hematologic cancer	3.06e-05	9.95e-05	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—hematologic cancer	3.06e-05	9.93e-05	CcSEcCtD
Sevoflurane—Vomiting—Prednisone—hematologic cancer	3.02e-05	9.82e-05	CcSEcCtD
Sevoflurane—Rash—Prednisone—hematologic cancer	3e-05	9.74e-05	CcSEcCtD
Sevoflurane—Dermatitis—Prednisone—hematologic cancer	3e-05	9.73e-05	CcSEcCtD
Sevoflurane—Headache—Prednisone—hematologic cancer	2.98e-05	9.67e-05	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.97e-05	9.65e-05	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—hematologic cancer	2.95e-05	9.59e-05	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—hematologic cancer	2.94e-05	9.56e-05	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—hematologic cancer	2.94e-05	9.55e-05	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—hematologic cancer	2.93e-05	9.51e-05	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—hematologic cancer	2.85e-05	9.26e-05	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—hematologic cancer	2.84e-05	9.21e-05	CcSEcCtD
Sevoflurane—Nausea—Prednisone—hematologic cancer	2.82e-05	9.17e-05	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—hematologic cancer	2.81e-05	9.13e-05	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—hematologic cancer	2.74e-05	8.9e-05	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—hematologic cancer	2.73e-05	8.88e-05	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—hematologic cancer	2.72e-05	8.83e-05	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—hematologic cancer	2.67e-05	8.66e-05	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—hematologic cancer	2.63e-05	8.54e-05	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—hematologic cancer	2.63e-05	8.53e-05	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—hematologic cancer	2.54e-05	8.23e-05	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—hematologic cancer	2.53e-05	8.21e-05	CcSEcCtD
Sevoflurane—Rash—Methotrexate—hematologic cancer	2.51e-05	8.14e-05	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—hematologic cancer	2.5e-05	8.13e-05	CcSEcCtD
Sevoflurane—Headache—Methotrexate—hematologic cancer	2.49e-05	8.08e-05	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—hematologic cancer	2.47e-05	8.02e-05	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—hematologic cancer	2.46e-05	7.99e-05	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—hematologic cancer	2.43e-05	7.91e-05	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—hematologic cancer	2.36e-05	7.68e-05	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—hematologic cancer	2.36e-05	7.67e-05	CcSEcCtD
Sevoflurane—Rash—Epirubicin—hematologic cancer	2.34e-05	7.61e-05	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—hematologic cancer	2.34e-05	7.61e-05	CcSEcCtD
Sevoflurane—Headache—Epirubicin—hematologic cancer	2.33e-05	7.57e-05	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—hematologic cancer	2.28e-05	7.39e-05	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—hematologic cancer	2.21e-05	7.17e-05	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—hematologic cancer	2.19e-05	7.1e-05	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—hematologic cancer	2.17e-05	7.05e-05	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—hematologic cancer	2.17e-05	7.04e-05	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—hematologic cancer	2.16e-05	7e-05	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—hematologic cancer	2.04e-05	6.64e-05	CcSEcCtD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	8.86e-06	8.2e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ADCY7—hematologic cancer	8.85e-06	8.2e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NCOA3—hematologic cancer	8.85e-06	8.2e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NUP214—hematologic cancer	8.79e-06	8.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HGF—hematologic cancer	8.74e-06	8.09e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CSF2—hematologic cancer	8.64e-06	8e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—IDH1—hematologic cancer	8.62e-06	7.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTR—hematologic cancer	8.61e-06	7.97e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCG2—hematologic cancer	8.61e-06	7.97e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.53e-06	7.9e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCC3—hematologic cancer	8.53e-06	7.89e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TXN—hematologic cancer	8.53e-06	7.89e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTO1—hematologic cancer	8.53e-06	7.89e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.52e-06	7.88e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO2—hematologic cancer	8.45e-06	7.82e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—IDH1—hematologic cancer	8.44e-06	7.82e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—IDH2—hematologic cancer	8.44e-06	7.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HMMR—hematologic cancer	8.44e-06	7.81e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCC3—hematologic cancer	8.35e-06	7.73e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TXN—hematologic cancer	8.35e-06	7.73e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTO1—hematologic cancer	8.35e-06	7.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—JAK1—hematologic cancer	8.34e-06	7.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PRKCG—hematologic cancer	8.34e-06	7.72e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SPHK1—hematologic cancer	8.34e-06	7.72e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTT1—hematologic cancer	8.19e-06	7.58e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SPHK1—hematologic cancer	8.17e-06	7.56e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—UGT1A1—hematologic cancer	8.02e-06	7.42e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SDC1—hematologic cancer	8.01e-06	7.41e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.96e-06	7.37e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ARNTL—hematologic cancer	7.94e-06	7.34e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—hematologic cancer	7.89e-06	7.3e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—UGT1A1—hematologic cancer	7.85e-06	7.27e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC22A1—hematologic cancer	7.8e-06	7.22e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CRABP1—hematologic cancer	7.8e-06	7.22e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.8e-06	7.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2RA—hematologic cancer	7.79e-06	7.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	7.73e-06	7.16e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ACP5—hematologic cancer	7.72e-06	7.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CA9—hematologic cancer	7.72e-06	7.14e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC22A1—hematologic cancer	7.64e-06	7.07e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CRABP1—hematologic cancer	7.64e-06	7.07e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOR2—hematologic cancer	7.62e-06	7.05e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALOX5—hematologic cancer	7.6e-06	7.03e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.53e-06	6.97e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PDGFB—hematologic cancer	7.52e-06	6.96e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.46e-06	6.9e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DCK—hematologic cancer	7.46e-06	6.9e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ASNS—hematologic cancer	7.46e-06	6.9e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALOX5—hematologic cancer	7.44e-06	6.89e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NUP98—hematologic cancer	7.36e-06	6.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CDK2—hematologic cancer	7.3e-06	6.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—IDH1—hematologic cancer	7.26e-06	6.72e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NUP98—hematologic cancer	7.21e-06	6.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TXN—hematologic cancer	7.18e-06	6.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCC3—hematologic cancer	7.18e-06	6.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTO1—hematologic cancer	7.18e-06	6.64e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ADCY7—hematologic cancer	7.14e-06	6.61e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOA3—hematologic cancer	7.14e-06	6.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.12e-06	6.59e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NUP214—hematologic cancer	7.09e-06	6.57e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HDC—hematologic cancer	7.07e-06	6.54e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SPHK1—hematologic cancer	7.02e-06	6.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK14—hematologic cancer	7e-06	6.48e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ADCY7—hematologic cancer	7e-06	6.48e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOA3—hematologic cancer	7e-06	6.48e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTR—hematologic cancer	6.95e-06	6.43e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCG2—hematologic cancer	6.95e-06	6.43e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NUP214—hematologic cancer	6.95e-06	6.43e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	6.91e-06	6.4e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO2—hematologic cancer	6.82e-06	6.31e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NQO1—hematologic cancer	6.81e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CD44—hematologic cancer	6.81e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCG2—hematologic cancer	6.81e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTR—hematologic cancer	6.81e-06	6.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—FN1—hematologic cancer	6.78e-06	6.28e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—hematologic cancer	6.75e-06	6.25e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—hematologic cancer	6.75e-06	6.25e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—UGT1A1—hematologic cancer	6.75e-06	6.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO2—hematologic cancer	6.68e-06	6.18e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTT1—hematologic cancer	6.61e-06	6.12e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC22A1—hematologic cancer	6.56e-06	6.08e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CRABP1—hematologic cancer	6.56e-06	6.08e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CG—hematologic cancer	6.49e-06	6.01e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTT1—hematologic cancer	6.47e-06	5.99e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CDA—hematologic cancer	6.47e-06	5.99e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SDC1—hematologic cancer	6.46e-06	5.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYCS—hematologic cancer	6.44e-06	5.96e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	6.4e-06	5.93e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ALOX5—hematologic cancer	6.4e-06	5.92e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PTPN11—hematologic cancer	6.38e-06	5.9e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SDC1—hematologic cancer	6.33e-06	5.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PC—hematologic cancer	6.22e-06	5.76e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NUP98—hematologic cancer	6.19e-06	5.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CREBBP—hematologic cancer	6.02e-06	5.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ADCY7—hematologic cancer	6.01e-06	5.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOA3—hematologic cancer	6.01e-06	5.57e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.01e-06	5.56e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GBA—hematologic cancer	6.01e-06	5.56e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NUP214—hematologic cancer	5.97e-06	5.53e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.91e-06	5.47e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.88e-06	5.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTR—hematologic cancer	5.85e-06	5.41e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCG2—hematologic cancer	5.85e-06	5.41e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO2—hematologic cancer	5.74e-06	5.31e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—hematologic cancer	5.71e-06	5.28e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.68e-06	5.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—hematologic cancer	5.56e-06	5.15e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—hematologic cancer	5.51e-06	5.1e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—hematologic cancer	5.51e-06	5.1e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTAP—hematologic cancer	5.5e-06	5.09e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NQO1—hematologic cancer	5.49e-06	5.08e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CD44—hematologic cancer	5.49e-06	5.08e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.48e-06	5.07e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SDC1—hematologic cancer	5.44e-06	5.03e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3R1—hematologic cancer	5.39e-06	4.99e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CD44—hematologic cancer	5.38e-06	4.98e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NQO1—hematologic cancer	5.38e-06	4.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.38e-06	4.98e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—JAK2—hematologic cancer	5.24e-06	4.85e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NCOR1—hematologic cancer	5.22e-06	4.83e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—hematologic cancer	5.22e-06	4.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.21e-06	4.82e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYCS—hematologic cancer	5.2e-06	4.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.2e-06	4.81e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	5.17e-06	4.78e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYCS—hematologic cancer	5.09e-06	4.71e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	5.06e-06	4.68e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—hematologic cancer	4.97e-06	4.6e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.91e-06	4.54e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FHL2—hematologic cancer	4.9e-06	4.54e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AGRN—hematologic cancer	4.81e-06	4.45e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.81e-06	4.45e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CD44—hematologic cancer	4.62e-06	4.28e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NQO1—hematologic cancer	4.62e-06	4.28e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.61e-06	4.27e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.58e-06	4.24e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—hematologic cancer	4.57e-06	4.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—IDH2—hematologic cancer	4.56e-06	4.22e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HMMR—hematologic cancer	4.56e-06	4.22e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.53e-06	4.19e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—hematologic cancer	4.49e-06	4.15e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYCS—hematologic cancer	4.38e-06	4.05e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HSP90AA1—hematologic cancer	4.35e-06	4.02e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.34e-06	4.01e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.28e-06	3.96e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.25e-06	3.93e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.21e-06	3.9e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.21e-06	3.9e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CA9—hematologic cancer	4.17e-06	3.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACP5—hematologic cancer	4.17e-06	3.86e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.12e-06	3.82e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.12e-06	3.82e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.11e-06	3.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EP300—hematologic cancer	4.1e-06	3.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SRC—hematologic cancer	3.99e-06	3.69e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—IDH1—hematologic cancer	3.92e-06	3.63e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.91e-06	3.62e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—hematologic cancer	3.88e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TXN—hematologic cancer	3.87e-06	3.59e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—hematologic cancer	3.86e-06	3.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—hematologic cancer	3.83e-06	3.55e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.79e-06	3.51e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.73e-06	3.45e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.72e-06	3.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—hematologic cancer	3.67e-06	3.4e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—hematologic cancer	3.65e-06	3.38e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.64e-06	3.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.64e-06	3.37e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.59e-06	3.33e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TGFB1—hematologic cancer	3.56e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—hematologic cancer	3.54e-06	3.28e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOR1—hematologic cancer	3.54e-06	3.28e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.54e-06	3.28e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.54e-06	3.28e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.45e-06	3.2e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.41e-06	3.15e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALB—hematologic cancer	3.36e-06	3.11e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NUP98—hematologic cancer	3.34e-06	3.1e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—hematologic cancer	3.3e-06	3.05e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.25e-06	3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.25e-06	3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NUP214—hematologic cancer	3.22e-06	2.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.22e-06	2.98e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.16e-06	2.92e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTR—hematologic cancer	3.16e-06	2.92e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTHFR—hematologic cancer	3.13e-06	2.9e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.13e-06	2.89e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO2—hematologic cancer	3.1e-06	2.87e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.06e-06	2.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—hematologic cancer	3.03e-06	2.81e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—hematologic cancer	3e-06	2.78e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.97e-06	2.75e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SDC1—hematologic cancer	2.94e-06	2.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—hematologic cancer	2.93e-06	2.71e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.9e-06	2.68e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.84e-06	2.63e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—hematologic cancer	2.81e-06	2.6e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.76e-06	2.55e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.75e-06	2.54e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALB—hematologic cancer	2.71e-06	2.51e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.69e-06	2.49e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALB—hematologic cancer	2.66e-06	2.46e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—hematologic cancer	2.63e-06	2.44e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.6e-06	2.4e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—hematologic cancer	2.57e-06	2.37e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.54e-06	2.35e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NQO1—hematologic cancer	2.5e-06	2.31e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CD44—hematologic cancer	2.5e-06	2.31e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—hematologic cancer	2.48e-06	2.29e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—EP300—hematologic cancer	2.45e-06	2.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CREBBP—hematologic cancer	2.44e-06	2.26e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.4e-06	2.22e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYCS—hematologic cancer	2.36e-06	2.19e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.35e-06	2.17e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.35e-06	2.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—hematologic cancer	2.31e-06	2.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3R1—hematologic cancer	2.18e-06	2.02e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.08e-06	1.93e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—hematologic cancer	2.07e-06	1.92e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—hematologic cancer	2.03e-06	1.88e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—hematologic cancer	2.02e-06	1.87e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—EP300—hematologic cancer	1.97e-06	1.83e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.97e-06	1.82e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—EP300—hematologic cancer	1.93e-06	1.79e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.91e-06	1.77e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.91e-06	1.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.81e-06	1.68e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—hematologic cancer	1.74e-06	1.61e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.69e-06	1.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—EP300—hematologic cancer	1.66e-06	1.54e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—hematologic cancer	1.48e-06	1.37e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.46e-06	1.35e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.43e-06	1.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.42e-06	1.31e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.32e-06	1.22e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.25e-06	1.16e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALB—hematologic cancer	1.23e-06	1.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—hematologic cancer	1.23e-06	1.14e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—hematologic cancer	1.19e-06	1.1e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.18e-06	1.09e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—hematologic cancer	1.17e-06	1.08e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.09e-06	1.01e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—hematologic cancer	1e-06	9.3e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—hematologic cancer	9.41e-07	8.71e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—EP300—hematologic cancer	8.97e-07	8.3e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.64e-07	6.14e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—hematologic cancer	5.42e-07	5.02e-06	CbGpPWpGaD
